mutual funds icici prudential nifty pharma index fund directgrowth

holdings

ICICI Prudential Nifty Pharma Index Fund Direct-Growth

Equity: Sectoral-Pharma - Growth (Open ended)

ICICI Prudential Nifty Pharma Index Fund Direct-GrowthNAV: 19.67 as on 07 Jul, 2026

Risk levelCategoryBenchmark

Factsheet

SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: NIFTY Pharma Total Return Index

NAV: ₹19.67-0.97%

08 Jul 2026

Holdings Analysis

Equity, debt and cash allocation snapshot with market cap distribution for ICICI Prudential Nifty Pharma Index Fund Direct-Growth.

Asset Allocation

As on 31 May 2026

Equity

99.50%

Others

0.50%

Market Cap Distribution

Large Cap (54.0%)

Mid Cap (37.5%)

Small Cap (8.5%)

Historical Asset Allocation

Asset	31 May 2026	30 Apr 2026	31 Mar 2026	28 Feb 2026	31 Jan 2026	31 Dec 2025
Equity	99.50%	99.94%	99.86%	99.35%	100.35%	99.95%
Debt	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Others (incl. cash)	0.50%	0.06%	0.14%	0.65%	-0.35%	0.05%
Commodities	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Real Estate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Portfolio Snapshot

No. of Securities

P/E Ratio

34.53

P/B Ratio

4.42

Top Holding %

21.33%

Top 5 Holdings %

54.69%

Top 10 Holdings %

77.69%

AUM

₹130 Cr

Expense Ratio

0.48%

Since Inception

20.89%

Max Drawdown

-0.17%

Alpha

-0.99%

Sharpe Ratio

0.97

Top Portfolio Holdings by Weight

Latest portfolio holdings sorted by allocation weight. Includes instrument name, sector, number of shares, market value (₹ Cr) and percentage of net assets. Switch dates or categories using the controls below.

Instrument	Sector	No. of Shares	Value (Rs. Cr)	Weight	Change
Sun Pharmaceutical Industries Ltd.	Healthcare	1,54,467	27.79	21.33%	-1.19%↓
Divis Laboratories Ltd.	Healthcare	18,530	12.35	9.48%	-0.24%↓
Dr. Reddys Laboratories Ltd.	Healthcare	88,902	11.59	8.89%	-0.59%↓
Cipla Ltd.	Healthcare	82,073	11.5	8.83%	0.16%↑
Lupin Ltd.	Healthcare	35,375	8.02	6.16%	-0.42%↓
Laurus Labs Ltd.	Healthcare	56,757	7.73	5.93%	0.89%↑
Torrent Pharmaceuticals Ltd.	Healthcare	15,249	6.73	5.16%	0.01%↑
Aurobindo Pharma Ltd.	Healthcare	40,776	5.82	4.46%	-0.11%↓
Glenmark Pharmaceuticals Ltd.	Healthcare	21,958	5	3.83%	-0.43%↓
Alkem Laboratories Ltd.	Healthcare	8,526	4.69	3.60%	-0.12%↓
Biocon Ltd.	Healthcare	1,04,117	4.46	3.43%	0.41%↑
Zydus Lifesciences Ltd.	Healthcare	36,488	3.93	3.02%	0.39%↑
Mankind Pharma Ltd.	Healthcare	16,497	3.92	3.01%	0.02%↑
Ipca Laboratories Ltd.	Healthcare	20,253	3.09	2.37%	-0.13%↓
Gland Pharma Ltd.	Healthcare	11,601	2.61	2.00%	0.36%↑
JB Chemicals & Pharmaceuticals Ltd.	Healthcare	11,932	2.59	1.99%	0.02%↑
Wockhardt Ltd.	Healthcare	12,045	2.45	1.88%	0.52%↑
Abbott India Ltd.	Healthcare	752	2.02	1.55%	-0.00%↓
Ajanta Pharma Ltd.	Healthcare	6,134	1.8	1.38%	-0.02%↓
Piramal Pharma Ltd.	Healthcare	90,398	1.56	1.20%	0.02%↑

Sector-wise Portfolio Allocation

Equity exposure by sector as a percentage of total net assets, tracked across recent portfolio dates. Identifies concentration risk and sector rotation trends in the fund's holdings.

Sector	31 May 2026	30 Apr 2026	31 Mar 2026	28 Feb 2026	31 Jan 2026	31 Dec 2025
Healthcare	99.50%	99.94%	99.86%	99.35%	100.35%	99.95%

Equity Insights

A detailed look at the equity holdings of this scheme — aggregated scores on value, momentum, quality parameters along with diversification and performance analysis.

Style Analysis

Value score

33.7 / 100

Weighted average Value score is 33.7. This indicates that portfolio is relatively reasonably valued using composite of value measures.

Price Momentum score

83.8 / 100

Weighted average Price Momentum score is 83.8. This indicates that portfolio has high momentum using composite of momentum measures.

Quality score

87.6 / 100

Weighted average Quality score is 87.6. This indicates that portfolio has high quality using composite of quality measures.

QVM score

83.2 / 100

Weighted average QVM score is 83.2. This indicates that portfolio has high QVM score and hence could be considered for investment.

Red Flags

Declining revenues

Following companies have seen their sales decline for 2 consecutive quarters (measured on yoy basis): Piramal Pharma Ltd.

Frequently Asked Questions

What are the top holdings of ICICI Prudential Nifty Pharma Index Fund Direct-Growth?

The top holdings of ICICI Prudential Nifty Pharma Index Fund Direct-Growth sorted by portfolio weight are listed in the Top Portfolio Holdings section of the Holdings tab.

How many stocks does ICICI Prudential Nifty Pharma Index Fund Direct-Growth hold in its portfolio?

ICICI Prudential Nifty Pharma Index Fund Direct-Growth holds 21 securities in its portfolio. The top 5 holdings account for 54.69% of the portfolio and the top 10 for 77.69% — a concentrated portfolio that amplifies stock-specific outcomes.

What is the sector allocation of ICICI Prudential Nifty Pharma Index Fund Direct-Growth?

The sector allocation of ICICI Prudential Nifty Pharma Index Fund Direct-Growth is in the Sector Allocation section, showing each industry's weight in the portfolio.

What is the equity and debt allocation of ICICI Prudential Nifty Pharma Index Fund Direct-Growth?

As of 31 May 2026, ICICI Prudential Nifty Pharma Index Fund Direct-Growth has 99.50% in equity, 0.00% in debt and 0.50% in cash/others. This asset mix determines the fund's overall risk-return profile.

What is the market cap allocation of ICICI Prudential Nifty Pharma Index Fund Direct-Growth?

ICICI Prudential Nifty Pharma Index Fund Direct-Growth's equity portfolio — Large Cap: 53.97%, Mid Cap: 37.55%, Small Cap: 8.49%. Market cap allocation determines the fund's risk profile — large cap offers stability while mid and small cap offer higher growth potential with higher volatility.

Is ICICI Prudential Nifty Pharma Index Fund Direct-Growth a concentrated or diversified fund?

ICICI Prudential Nifty Pharma Index Fund Direct-Growth holds 21 securities, with the top 10 accounting for 77.69% of the portfolio and the top 5 for 54.69%. With fewer than 30 holdings, this is a concentrated fund — each stock has a meaningful impact on performance.

What is the credit quality of ICICI Prudential Nifty Pharma Index Fund Direct-Growth?

The credit quality breakdown of ICICI Prudential Nifty Pharma Index Fund Direct-Growth's debt portfolio is in the Credit Rating section. For equity-oriented funds, this section may not be applicable.

How often does ICICI Prudential Nifty Pharma Index Fund Direct-Growth change its portfolio?

The portfolio currently holds 21 securities with the top 10 accounting for 77.69% as of 31 May 2026. Portfolio turnover reflects how actively the fund manager trades. A high turnover increases transaction costs while a low turnover reflects a buy-and-hold approach. Historical asset allocation snapshots across multiple dates are in the Holdings Analysis section.

What is the PE ratio of ICICI Prudential Nifty Pharma Index Fund Direct-Growth's portfolio?

The weighted average PE ratio of ICICI Prudential Nifty Pharma Index Fund Direct-Growth's portfolio is 34.53 and the PB ratio is 4.42. These metrics reflect the overall valuation and interest rate sensitivity of the portfolio.

When is the latest portfolio disclosure for ICICI Prudential Nifty Pharma Index Fund Direct-Growth?

The latest portfolio disclosure for ICICI Prudential Nifty Pharma Index Fund Direct-Growth is as of 31 May 2026. Mutual funds and ETFs in India are required to disclose their full portfolio monthly, within 10 business days of month-end. You can switch between historical disclosure dates using the date selector in the Top Portfolio Holdings section.

Loading…

Asset

31 May 2026

30 Apr 2026

31 Mar 2026

28 Feb 2026

31 Jan 2026

31 Dec 2025

Equity

99.50%

99.94%

99.86%

99.35%

100.35%

99.95%

Debt

0.00%

Others (incl. cash)

0.50%

0.06%

0.14%

0.65%

-0.35%

0.05%

Commodities

0.00%

Real Estate

0.00%

Instrument

Sector

No. of Shares

Value (Rs. Cr)

Weight

Change

Sun Pharmaceutical Industries Ltd.

Healthcare

1,54,467

27.79

21.33%

-1.19%↓

Divis Laboratories Ltd.

Healthcare

18,530

12.35

9.48%

-0.24%↓

Dr. Reddys Laboratories Ltd.

Healthcare

88,902

11.59

8.89%

-0.59%↓

Cipla Ltd.

Healthcare

82,073

11.5

8.83%

0.16%↑

Lupin Ltd.

Healthcare

35,375

8.02

6.16%

-0.42%↓

Laurus Labs Ltd.

Healthcare

56,757

7.73

5.93%

0.89%↑

Torrent Pharmaceuticals Ltd.

Healthcare

15,249

6.73

5.16%

0.01%↑

Aurobindo Pharma Ltd.

Healthcare

40,776

5.82

4.46%

-0.11%↓

Glenmark Pharmaceuticals Ltd.

Healthcare

21,958

3.83%

-0.43%↓

Alkem Laboratories Ltd.

Healthcare

8,526

4.69

3.60%

-0.12%↓

Biocon Ltd.

Healthcare

1,04,117

4.46

3.43%

0.41%↑

Zydus Lifesciences Ltd.

Healthcare

36,488

3.93

3.02%

0.39%↑

Mankind Pharma Ltd.

Healthcare

16,497

3.92

3.01%

0.02%↑

Ipca Laboratories Ltd.

Healthcare

20,253

3.09

2.37%

-0.13%↓

Gland Pharma Ltd.

Healthcare

11,601

2.61

2.00%

0.36%↑

JB Chemicals & Pharmaceuticals Ltd.

Healthcare

11,932

2.59

1.99%

0.02%↑

Wockhardt Ltd.

Healthcare

12,045

2.45

1.88%

0.52%↑

Abbott India Ltd.

Healthcare

752

2.02

1.55%

-0.00%↓

Ajanta Pharma Ltd.

Healthcare

6,134

1.8

1.38%

-0.02%↓

Piramal Pharma Ltd.

Healthcare

90,398

1.56

1.20%